2-异丙基-5-苯基-1,3,4-恶二唑 | 104217-22-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-异丙基-5-苯基-1,3,4-恶二唑
• 英文名称: 2-phenyl-5-(propan-2-yl)-1,3,4-oxadiazole
• 英文别名: 2-isopropyl-5-phenyl-1,3,4-oxadiazole；2-isopropyl-5-phenyl-[1,3,4]oxadiazole；2-Isopropyl-5-phenyl-1,3,4-oxdiazol；2-phenyl-5-propan-2-yl-1,3,4-oxadiazole
• CAS: 104217-22-3
• 化学式: C₁₁H₁₂N₂O
• mdl: MFCD07517863
• 分子量: 188.229
• InChiKey: AWIGHZUAXGVJSJ-UHFFFAOYSA-N

物化性质

• 沸点：
  301.8±25.0 °C(Predicted)
• 密度：
  1.081±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.272
• 拓扑面积：
  38.9
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2,4,6-三甲基苯胺 、 2-异丙基-5-苯基-1,3,4-恶二唑 在 三氟乙酸吡啶 作用下， 反应 12.0h， 以28%的产率得到3-isopropyl-4-mesityl-5-phenyl-4H-1,2,4-triazole
  参考文献：
  名称：

  Tunable protic ionic liquids as solvent-catalysts for improved synthesis of multiply substituted 1,2,4-triazoles from oxadiazoles and organoamines

  摘要：

  More than green alternatives to traditional volatile molecular organic solvents, protic ionic liquids as dual solvent-catalysts have been successfully used to promote reactions of organoamines with oxadiazoles to afford sterically hindered 1,2,4-triazoles. Among the tested protic ionic liquids, pyridinium trifluoroacetate and acetate showed the highest efficiency for the reactions of arylamines and alkylamines, respectively, indicating that tunable catalysis could be readily effected with protic ionic liquid solvent-catalysts by simply tuning their cation and anion counterparts. A general and efficient approach has been developed for synthesis of multiply substituted 1,2,4-triazoles based on the tunable protic ionic liquid solvent-catalyst systems. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2012.03.114
• 作为产物：
  描述：

  苯甲酰肼 在 sodium hypochlorite 作用下， 以 水 、 叔丁醇 为溶剂， 反应 0.75h， 生成 2-异丙基-5-苯基-1,3,4-恶二唑
  参考文献：
  名称：

  次氯酸钠介导的酰肼和醛类化合物合成2,5-二取代的1,3,4-恶二唑

  摘要：

  已经开发了一种简单方便的合成2,5-二取代的1,3,4-恶二唑的方法。通过脂族和芳族酰肼和醛原位生成的NaOCl介导的N-酰基via的氧化环化反应，可以中等到高收率获得结构上不同的对称和不对称2,5-二取代的1,3,4-恶二唑。

  DOI：

  10.1007/s10593-020-02669-6

文献信息

• SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
  申请人：GLAXOSMITHKLINE LLC

  公开号：US20150152108A1

  公开（公告）日：2015-06-04

  The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本发明涉及新型取代桥式脲化合物，相应的相关类似物，药物组合物以及其使用方法。本发明的抑制素调节化合物可用于延长细胞寿命，并治疗和/或预防各种疾病和疾病，包括但不限于与衰老或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块疾病、炎症、癌症和/或潮红有关的疾病或疾病，以及那些会受益于增加线粒体活性的疾病或疾病。本发明还涉及包含抑制素调节化合物与另一治疗剂组合的组合物。
• 2,4,6-Tris[(4-dichloroiodo)phenoxy)]-1,3,5-triazine as a New Recyclable Hypervalent Iodine(III) Reagent for Chlorination and Oxidation Reactions
  作者：Nandkishor Karade、Prerana Thorat、Bhagyashree Bhong

  DOI：10.1055/s-0033-1339495

  日期：——

  reagent 2,4,6-tris[(4-dichloroiodo)phenoxy)]-1,3,5-triazine can be applied also for the oxidative synthesis of 1,3,4-oxadiazoles and 1,2,4-thiadiazoles under mild conditions in excellent yields. The recyclability of the 2,4,6-tris[(4-dichloroiodo)phenoxy)]-1,3,5-triazine was possible owing to the facile recovery and reuse of the coproduced 2,4,6-tris(4-iodophenoxy)-1,3,5-triazine from the reaction mixture

  2,4,6-三[(4-二氯碘)苯氧基)]-1,3,5-三嗪作为（二氯碘）苯的一种新型可回收非聚合类似物的合成分两步完成，使用2,4， 6-三氯-1,3,5-三嗪和4-碘苯酚。2,4,6-tris[(4-dichloroiodo)phenoxy)]-1,3,5-triazine 在各种活化芳烃、烯烃和 1,3-二酮的氯化反应中的应用得到了证明。试剂2,4,6-三[(4-二氯碘)苯氧基)]-1,3,5-三嗪也可用于1,3,4-恶二唑和1,2,4-噻二唑的氧化合成在温和的条件下以优异的产量。由于联产的 2,4,6-三(4-二氯碘)苯氧基)]-1,3,5-三嗪易于回收和再利用，2,4,6-三[(4-二氯碘)苯氧基)]-1,3,5-三嗪的可回收性是可能的。碘苯氧基)-1,3,5-三嗪从反应混合物中分离出来，因为它实际上不溶于甲醇。
• [EN] AMIDE COMPOUNDS AND USE THEREOF<br/>[FR] COMPOSÉS AMIDE ET LEUR UTILISATION
  申请人：ALPHALA CO LTD

  公开号：WO2018140338A1

  公开（公告）日：2018-08-02

  Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof, in which each of variables R1, R2, L, and Z is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.

  下面公开了式(I)的化合物及其药用盐，其中变量R1、R2、L和Z在此处有定义。还公开了使用式(I)的化合物或其盐以及含有相同化合物的药物组合物来降低血糖水平和治疗胰高血糖素相关疾病的方法。
• [EN] COMPOUNDS AS RAS INHIBITORS AND USE THEREOF<br/>[FR] COMPOSÉS UTILISÉS COMME INHIBITEURS DE RAS ET LEUR UTILISATION
  申请人：DE SHAW RES LLC

  公开号：WO2019055540A1

  公开（公告）日：2019-03-21

  A compound of Formula (Ia) or (Ib), or a pharmaceutically acceptable salt thereof is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.

  描述了一个式(Ia)或(Ib)的化合物，或其药用盐，其中取代基如本文所定义。还描述了包含相同化合物的药物组合物以及使用相同化合物的方法。
• [EN] SUBSTITUTED PYRIDAZINONE FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES<br/>[FR] PYRIDAZINONE SUBSTITUÉE DESTINÉE À ÊTRE UTILISÉE DANS LE TRAITEMENT DE MALADIES NEUROMUSCULAIRES
  申请人：EDGEWISE THERAPEUTICS INC

  公开号：WO2021231615A1

  公开（公告）日：2021-11-18

  Substituted pyridazinone compounds, conjugates, and pharmaceutical compositions for use in the treatment of neuromuscular diseases, such as Duchenne Muscular Dystrophy (DMD), are disclosed herein. The disclosed compounds are useful, among other things, in the treating of DMD and modulating inflammatory inhibitors IL-1, IL-6 or TNF-α.

  本文披露了用于治疗神经肌肉疾病，如杜欣氏肌肉萎缩症（DMD）的吡啶并嗪酮化合物、结合物和药物组合物。所披露的化合物在治疗DMD和调节炎症抑制剂IL-1、IL-6或TNF-α等方面具有用途。